Skip to main content
. Author manuscript; available in PMC: 2020 Feb 4.
Published in final edited form as: Subst Abus. 2019 Feb 4;40(2):132–135. doi: 10.1080/08897077.2019.1569192

Table 2.

Data availability, primary outcomes, and patient satisfaction.

Data/outcome Standard
buprenorphine
(n=10)
Standard
buprenorphine plus
CBT4CBT-
Buprenorphine
(n=10)
Total (N=20) F or χ2 p Effect size (d)

Data availability and primary outcomes, mean+SD
 Days in treatment (max=84) 68.6 ± 32.6 82.6 ± 4.4 75.6 ± 23.8   1.81 .19
 Number assessment visits (max=11)  7.3 ± 3.9   9.1 ± 1.7 8.2 ± 3.1   1.811 .20
 End of treatment buprenorphine dose 15.1 ± 7.7 14.8 ± 5.7 15.0 ± 6.5     .01 .92
 Number urine specimens collected (max=11)  8.4 ± 3.3   9.3 ± 1.7  8.9 ± 2.6     .516 .48
 Percent of expected urine specimens collected 79.6 ± 20.5 79.2 ± 15.8 79.4 ± 17.6     .003 .96 .
 Number of urine specimens free of allillicit drugs 2.3 ± 3.0 7.3 ± 2.8 4.9 ± 3.8 13.60 .01 1.25
 % opioid-free urine specimens 63.9 ± 36.6 91.3 ± 20.8 78.3 ± 31.8   4.16 .05 0.88
 % urine specimens free of all drugs 29.9 ± 38.1 81.6 ± 29.7 57.1 ± 42.3 11.01 .004 1.21
Evaluation of the CBT4CBT-Buprenorphine program: 1 = Not at all, 2 = A little, 3 = Somewhat, 4 = A great deal, 5 = Extremely
 I learned things I didn’t know from the “bup” videos (mean ± SD)     4.2 ± 0.4
 I enjoyed the “bup” videos     4.1 ± 0.6
 I would recommend the “bup” videosto other people     4.4 ± 0.5
 I would feel able to do the examples in my own life after watching homework in program     3.9 ± 0.8
 Doing the homework assignments during the week helped me     4.0 ± 0.9
 The homework gave me tools     4.0 ± 0.9